PreciseDx

New York, NY · Founded 2020 · Privately Held (backing)

Developer of artificial intelligence-guided pathology diagnostics designed to improve patient outcomes in the field of cancer and other diseases. PreciseDx is based in New York, NY and was founded in 2020. It was valued at $41.5 million at its later-stage round in Jun 2025, the last priced event on record. It has raised $42.8 million across 2 recorded rounds; the latest was an $11.2 million early-stage round in May 2025.

PMV mark · valuation
$41.5M
Oct 2026
Priced at
its later-stage round
Jun 2025
Total raised
$42.8M
Last round
Early Stage VC
May 2025

Who backs PreciseDx?

11 investors
InvestorType
Labcorp Venture FundVenture capital
MSD Global Health Innovation FundVenture capital
GenHenn CapitalFamily office
Agilent Technologies—
Eventide Asset Management—
Gershon Capital—
Hobart Group—
IBM Ventures—
Mount Sinai—
Philips Ventures—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

PreciseDx investors

11 investors are on record for PreciseDx, including Labcorp Venture Fund, MSD Global Health Innovation Fund, GenHenn Capital and Agilent Technologies. The early-stage round in May 2025 drew 9 investors.

Free account
More of PreciseDx with a free account
  • ·The complete investor list: 11 names
  • ·Watch PreciseDx: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like PreciseDx. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View